ChloroquineV1, Main, Exploration, bibRecord, 003193

Prognosis and therapy of polymyositis/ dermatomyositis

Identifieur interne : 003193 ( Main/Exploration ); précédent : 003192; suivant : 003194

Prognosis and therapy of polymyositis/ dermatomyositis

Auteurs : Denny L. Tuffanelli [États-Unis] ; Paul E. Lavoie [États-Unis]

Source :

Clinics in Dermatology [ 0738-081X ] ; 1988.

RBID : ISTEX:4B3F4D37160DE39907704E9668BBC3D677FAFABB

English descriptors

Teeft :
- Acad dermatol, Acanthosis nigricans, Active disease, Arch dermatol, Arthritis rheum, Aspiration pneumonia, Azathioprine, Banker type, Beneficial effects, Calcinosis, Callen, Carcinoma, Childhood dermatomyositis, Classic cutaneous lesions, Clin, Clinical trial, Complement membrane attack, Complete remission, Computerassisted analysis, Corticosteroid, Corticosteroid therapy, Cutaneous, Cutaneous lesions, Cutaneous vasculitis, Dermatol, Dermatology, Dermatomyositis, Dermatomyositis hood, Disease activity, Dos, Enzyme levels, Fewer side effects, Functional disability, Gastrointestinal perforations, Good prognosis, High doses, Hydroxychloroquine, Immunosuppressive, Immunosuppressive therapy, Inflammatory response, Intern, Juvenile dermatomyositis, Laboratory tests, Lavoie, Lesion, Lung disease, Lupus erythematosus, Major problem, Malignancy, Methotrexate, Microvascular deposition, Muscle biopsy, Muscle disease, Muscle enzymes, Muscle strength, Muscle weakness, Myositis, Nasopharyngeal carcinoma, Oral methotrexate, Pediatr, Pediatr clin, Pediatr dermatol, Pharyngeal involvement, Physical therapy, Plasmapheresis, Polymyositis, Poor prognostic sign, Prednisolone, Prednisone, Prognosis, Pulse therapy, Recent series, Remission, Rheum, Rheumatol, Side effects, Skin lesions, Steroid, Steroid therapy, Such patients, Surgical removal, Systemic corticosteroids, Systemic disease, Systemic inflammation, Therapy, Tuffanelli, Ventilatory failure.

Url:

https://api.istex.fr/ark:/67375/6H6-9B19F9XD-8/fulltext.pdf

DOI: 10.1016/0738-081X(88)90052-1

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 000290
to stream Istex, to step Curation: 000290
to stream Istex, to step Checkpoint: 001F55
to stream Main, to step Merge: 003264
to stream Main, to step Curation: 003193

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Prognosis and therapy of polymyositis/ dermatomyositis</title>
<author><name sortKey="Tuffanelli, Denny L" sort="Tuffanelli, Denny L" uniqKey="Tuffanelli D" first="Denny L." last="Tuffanelli">Denny L. Tuffanelli</name>
</author>
<author><name sortKey="Lavoie, Paul E" sort="Lavoie, Paul E" uniqKey="Lavoie P" first="Paul E." last="Lavoie">Paul E. Lavoie</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4B3F4D37160DE39907704E9668BBC3D677FAFABB</idno>
<date when="1988" year="1988">1988</date>
<idno type="doi">10.1016/0738-081X(88)90052-1</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-9B19F9XD-8/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000290</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000290</idno>
<idno type="wicri:Area/Istex/Curation">000290</idno>
<idno type="wicri:Area/Istex/Checkpoint">001F55</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001F55</idno>
<idno type="wicri:doubleKey">0738-081X:1988:Tuffanelli D:prognosis:and:therapy</idno>
<idno type="wicri:Area/Main/Merge">003264</idno>
<idno type="wicri:Area/Main/Curation">003193</idno>
<idno type="wicri:Area/Main/Exploration">003193</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Prognosis and therapy of polymyositis/ dermatomyositis</title>
<author><name sortKey="Tuffanelli, Denny L" sort="Tuffanelli, Denny L" uniqKey="Tuffanelli D" first="Denny L." last="Tuffanelli">Denny L. Tuffanelli</name>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>From the Department of Medicine (Dermatology), University of California, San Francisco School of Medicine, San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Lavoie, Paul E" sort="Lavoie, Paul E" uniqKey="Lavoie P" first="Paul E." last="Lavoie">Paul E. Lavoie</name>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>From the Department of Medicine (Dermatology), University of California, San Francisco School of Medicine, San Francisco</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Clinics in Dermatology</title>
<title level="j" type="abbrev">CID</title>
<idno type="ISSN">0738-081X</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1988">1988</date>
<biblScope unit="volume">6</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="93">93</biblScope>
<biblScope unit="page" to="104">104</biblScope>
</imprint>
<idno type="ISSN">0738-081X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0738-081X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acad dermatol</term>
<term>Acanthosis nigricans</term>
<term>Active disease</term>
<term>Arch dermatol</term>
<term>Arthritis rheum</term>
<term>Aspiration pneumonia</term>
<term>Azathioprine</term>
<term>Banker type</term>
<term>Beneficial effects</term>
<term>Calcinosis</term>
<term>Callen</term>
<term>Carcinoma</term>
<term>Childhood dermatomyositis</term>
<term>Classic cutaneous lesions</term>
<term>Clin</term>
<term>Clinical trial</term>
<term>Complement membrane attack</term>
<term>Complete remission</term>
<term>Computerassisted analysis</term>
<term>Corticosteroid</term>
<term>Corticosteroid therapy</term>
<term>Cutaneous</term>
<term>Cutaneous lesions</term>
<term>Cutaneous vasculitis</term>
<term>Dermatol</term>
<term>Dermatology</term>
<term>Dermatomyositis</term>
<term>Dermatomyositis hood</term>
<term>Disease activity</term>
<term>Dos</term>
<term>Enzyme levels</term>
<term>Fewer side effects</term>
<term>Functional disability</term>
<term>Gastrointestinal perforations</term>
<term>Good prognosis</term>
<term>High doses</term>
<term>Hydroxychloroquine</term>
<term>Immunosuppressive</term>
<term>Immunosuppressive therapy</term>
<term>Inflammatory response</term>
<term>Intern</term>
<term>Juvenile dermatomyositis</term>
<term>Laboratory tests</term>
<term>Lavoie</term>
<term>Lesion</term>
<term>Lung disease</term>
<term>Lupus erythematosus</term>
<term>Major problem</term>
<term>Malignancy</term>
<term>Methotrexate</term>
<term>Microvascular deposition</term>
<term>Muscle biopsy</term>
<term>Muscle disease</term>
<term>Muscle enzymes</term>
<term>Muscle strength</term>
<term>Muscle weakness</term>
<term>Myositis</term>
<term>Nasopharyngeal carcinoma</term>
<term>Oral methotrexate</term>
<term>Pediatr</term>
<term>Pediatr clin</term>
<term>Pediatr dermatol</term>
<term>Pharyngeal involvement</term>
<term>Physical therapy</term>
<term>Plasmapheresis</term>
<term>Polymyositis</term>
<term>Poor prognostic sign</term>
<term>Prednisolone</term>
<term>Prednisone</term>
<term>Prognosis</term>
<term>Pulse therapy</term>
<term>Recent series</term>
<term>Remission</term>
<term>Rheum</term>
<term>Rheumatol</term>
<term>Side effects</term>
<term>Skin lesions</term>
<term>Steroid</term>
<term>Steroid therapy</term>
<term>Such patients</term>
<term>Surgical removal</term>
<term>Systemic corticosteroids</term>
<term>Systemic disease</term>
<term>Systemic inflammation</term>
<term>Therapy</term>
<term>Tuffanelli</term>
<term>Ventilatory failure</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="Tuffanelli, Denny L" sort="Tuffanelli, Denny L" uniqKey="Tuffanelli D" first="Denny L." last="Tuffanelli">Denny L. Tuffanelli</name>
</region>
<name sortKey="Lavoie, Paul E" sort="Lavoie, Paul E" uniqKey="Lavoie P" first="Paul E." last="Lavoie">Paul E. Lavoie</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003193 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003193 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:4B3F4D37160DE39907704E9668BBC3D677FAFABB
   |texte=   Prognosis and therapy of polymyositis/ dermatomyositis
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

Prognosis and therapy of polymyositis/ dermatomyositis

Prognosis and therapy of polymyositis/ dermatomyositis

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri